According to The Insight Partners market research study of ‘Middle East and Africa Biofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Analysis by product, wound, and end-user’ the Middle East and Africa biofilms treatment market is expected to reach US$ 197.81 million in 2027 from US$ 116.77 million in 2019. The market is estimated to grow with a CAGR of 6.9% from 2020-2027. The report provides trends prevailing in the Middle East and Africa biofilms treatment market and the factors driving market along with those that act as hindrances.
Based on the product, the Middle East and Africa the biofilms treatment market, is segmented into debridement equipment, gauzes and dressings, grafts and matrices, and others. The gauzes and dressings segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. Wound dressings like polyacrylate fibers are effective in disrupting the biofilm matrix which further helps in enhancing the efficacy of antimicrobial agents such as silver. After the process of debridement, dressings along with topical agents are used to prevent or disrupt the biofilm on the wound surface. There are several factors which need to be considered before applying it on the wound. The dressing should provide protection to the periwound skin, form an effective bacterial barrier, minimal pain during application and removal, conforming to wound shape, free of toxic or irritant extractable and dressings that does not release particles or fibers in to the wound. Many companies are developing advanced dressings to prevent biofilms. For instance, ConvaTec Inc. has developed Hydrofiber Technology where the soft absorbent material of the dressing forms gel when it comes in contact with wound fluid. This technology reduces the dead space where bacteria can grow and also provides rapid and sustained antimicrobial activity. Furthermore, gauzes are available in woven and nonwoven forms which have high absorbency and can be applied on both infected as well as non-infected wounds.
The growth of this market is estimated to grow owing to key driving factors such as the higher incidences of diabetes and related illnesses and the growing incidences of pressure ulcers amongst aging population. However, the market is expected experiencing slow growth during the forecast period owing to the concerns regarding the treatment of biofilms in the human body.
Coloplast Group, MiMedx, ConvaTec Group Plc are among the leading companies operating in the Middle East and Africa biofilms treatment market.
The report segments Middle East and Africa Biofilms Treatment Market as Follows:
By Product
- Gauzes and Dressings
- Debridement Equipment
- Grafts and Matrices
- Others
By Wound
- Traumatic and Surgical Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Others
By End User
- Hospitals
- Home Care Settings
- Others
By Country
- Middle East and Africa
- UAE
- South Africa
- Saudi Arabia
- Rest of Middle East and Africa
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com